Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19

Several efforts to repurpose drugs for COVID-19 treatment have largely either failed to identify a suitable agent or agents identified did not translate to clinical use. Reasons that have been suggested to explain the failures include use of inappropriate doses, that are not clinically achievable, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bello, Shaibu Oricha, Yunusa, Abdulmajeed, Adamu, Adamu Ahmed, Imam, Mustapha Umar, Bello, Muhammad Bashir, Shuaibu, Abdulmalik, Igumbor, Ehimario Uche, Habib, Zaiyad Garba, Popoola, Mustapha Ayodele, Ochu, Chinwe Lucia, Bello, Aishatu Yahaya, Deeni, Yusuf Yahaya, Okoye, Ifeoma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014809/
https://www.ncbi.nlm.nih.gov/pubmed/36937851
http://dx.doi.org/10.3389/fphar.2023.1130828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014809/
https://www.ncbi.nlm.nih.gov/pubmed/36937851
http://dx.doi.org/10.3389/fphar.2023.1130828

Ejemplares similares